Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer Progression-Reference-Cited by-同舟云学术

Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer Progression

Published:2013-08 Issue:3 Volume:154 Page:556-568
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Chan Chia-Hsin,Morrow John Kenneth,Li Chien-Feng,Gao Yuan,Jin Guoxiang,Moten Asad,Stagg Loren J.,Ladbury John E.,Cai Zhen,Xu Dazhi,Logothetis Christopher J.,Hung Mien-Chie,Zhang Shuxing,Lin Hui-Kuan

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference42 articles.

1. Development of sulfonamide AKT PH domain inhibitors;Ahad;Bioorg. Med. Chem.,2011

2. Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase;Bornstein;J. Biol. Chem.,2003

3. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27;Carrano;Nat. Cell Biol.,1999

4. Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis;Chan;Nat. Cell Biol.,2010

5. Regulation of Skp2 expression and activity and its role in cancer progression;Chan;ScientificWorldJournal,2010

Cited by 333 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A patent review of SCF E3 ligases inhibitors for cancer：Structural design, pharmacological activities and structure–activity relationship;European Journal of Medicinal Chemistry;2024-11

2. Exploring Ubiquitin-specific proteases as therapeutic targets in Glioblastoma;Pathology - Research and Practice;2024-08

3. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches;Molecular Cancer;2024-07-25

4. In silico approaches for drug repurposing in oncology: a scoping review;Frontiers in Pharmacology;2024-06-11

5. Targeting senescent cells to reshape the tumor microenvironment and improve anticancer efficacy;Seminars in Cancer Biology;2024-06